Jun 25, 2026 04:04PM
Jun 10, 2026 07:12AM
Jun 9, 2026 06:52AM
Jun 8, 2026 12:26PM
Jun 8, 2026 11:41AM
Jun 8, 2026 07:00AM
May 15, 2026 03:10AM Piper Sandler Downgrades Tango Therapeutics Inc. (TNGX) to Neutral
May 14, 2026 04:13PM
May 14, 2026 02:40PM
May 14, 2026 02:53AM
May 13, 2026 04:08PM
May 4, 2026 02:27PM
Apr 28, 2026 02:37PM
Apr 27, 2026 07:30AM Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Stifel on Higher PRMT5 Inhibitor Conviction
Apr 20, 2026 12:17PM
Apr 15, 2026 09:05AM
Apr 13, 2026 04:09PM
Apr 13, 2026 05:52AM
Apr 2, 2026 05:12AM
Mar 27, 2026 04:56AM
Mar 9, 2026 07:55AM Tango Therapeutics Inc. (TNGX) PT Raised to $24 at Stifel After Model Update
Mar 5, 2026 04:46PM
Mar 5, 2026 10:30AM
Mar 5, 2026 07:37AM
Feb 27, 2026 05:30PM
Feb 26, 2026 01:25PM
Feb 23, 2026 04:02AM
Jan 12, 2026 08:45AM Tango Therapeutics (TNGX) Reiterated at Buy by Stifel After Pipeline Updates
Dec 22, 2025 07:06AM
Dec 3, 2025 04:06PM
Nov 21, 2025 08:37AM
Nov 21, 2025 08:34AM
Nov 4, 2025 09:04AM
Oct 27, 2025 06:44AM
Oct 24, 2025 06:42AM Tango Therapeutics Inc. (TNGX) PT Raised to $12 at Guggenheim
Oct 23, 2025 11:39AM
Oct 23, 2025 07:25AM
Aug 25, 2025 04:09PM
Aug 19, 2025 06:18AM
Aug 5, 2025 07:04AM
Jun 30, 2025 06:52AM
Jun 27, 2025 07:03AM Tango Therapeutics (TNGX) Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lun
May 21, 2025 07:01AM
May 12, 2025 07:04AM
Apr 14, 2025 06:53AM
Jan 2, 2025 12:51PM
Nov 6, 2024 07:15AM
Nov 6, 2024 07:11AM
Nov 6, 2024 07:02AM Tango Therapeutics, Inc (TNGX) Reports Positive TNG462 Clinical Data, Provides Update on PRMT5 Development Program
Oct 28, 2024 07:29AM

421,632 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All